CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding CymaBay Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 650 | 0 | −650 (−100.0%) |
| Value | $21.1K | $0 | −$21.1K (−100.0%) |
New holders (0)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
None.
Sold out (1)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| IFP Advisors, Inc | 650 | $21.1K |